Home › Medicine › Cipla Usa, Inc.

Cipla Usa, Inc.

Check your batch

Check the batch codes below. If yours matches, return it for a refund rather than take it.

Class II

  • May cause temporary or medically reversible harm. Serious consequences are unlikely.
  • Refunds don't require a receipt, and you don't need proof of purchase.
  • FDA status: Ongoing.

What was recalled

Source: FDA · synced 29 Jul 2026 13:14
Check your batch Filed 2026-07-08

CGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-410-02

Check these codes: Lot #: 5PB0465, 5PB0466, 5PB0557, Exp 4/30/2027; 5PB0629, 5PB0630, 5PB0633, 5PB0637, 5PB0638, Exp 6/30/2027

31,824 bottles · distributed usa nationwide Recall D-0661-2026 on FDA.gov ↗
Ad slot · height reserved before load

Watch Cipla Usa, Inc. for new recalls

One email per recall. Nothing else, ever.